Curated Wealth Partners »

Atea Pharmaceuticals shares owned by Curated Wealth Partners

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Curated Wealth Partners from 13F filings

Historical chart of Curated Wealth Partners investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Curated Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Curated Wealth Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $671k 695k 0.97

More positions owned by Curated Wealth Partners

S&p Global (SPGI)
Procter & Gamble Company (PG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Target Corporation (TGT)
Broadcom (AVGO)
Charles Schwab Corporation (SCHW)
Parker-Hannifin Corporation (PH)
Brightstar Lottery Shs Usd (BRSL)
Tesla Motors (TSLA)
Amphenol Corp Cl A (APH)
Cummins (CMI)
Packaging Corporation of America (PKG)
ResMed (RMD)
Abbott Laboratories (ABT)
Trane Technologies SHS (TT)

View all positions for Curated Wealth Partners

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Capital Management
Bain Capital Life Sciences Investors
Two Sigma Investments
Geode Capital Management
State Street Corporation
Acadian Asset Management
Dimensional Fund Advisors
Rosalind Advisors
Renaissance Technologies
Morgan Stanley
Curated Wealth Partners

View all funds holding Atea Pharmaceuticals